MTMohammad A. Tabatabai

Mohammad A. Tabatabai

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mohammad A. Tabatabai has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A flexible multivariable model for Phytoplankton growth

    by Mohammad A. Tabatabai, Wayne M. Eby, Sejong Bae, Karan P. Singh

    We introduce a new multivariable model to be used to studythe growth dynamics of phytoplankton as a function of both time and theconcentration of nutrients. This model is applied to a set of experimentaldata which describes the rate of growth as a function of these two variables.The form of the model allows easy extension to additional variables. Thus, themodel can be used to analyze experimental data regarding the effects ofvarious factors on phytoplankton growth rate. Such a model will also be usefulin analysis of the role of concentration of various nutrients or traceelements, temperature, and light intensity, or other important explanatoryvariables, or combinations of such variables, in analyzing phytoplanktongrowth dynamics.


  • Open Access

    T model of growth and its application in systems of tumor-immunedynamics

    by Mohammad A. Tabatabai, Wayne M. Eby, Karan P. Singh, Sejong Bae

    In this paper we introduce a new growth model called T growth model. This model is capable of representing sigmoidal growth as well as biphasic growth. This dual capability is achieved without introducing additional parameters. The T model is useful in modeling cellular proliferation or regression of cancer cells, stem cells, bacterial growth and drug dose-response relationships. We recommend usage of the T growth model for the growth of tumors as part of any system of differential equations. Use of this model within a system will allow more flexibility in representing the natural rate of tumor growth. For illustration, we examine some systems of tumor-immune interaction in which the T growth rate is applied. We also apply the model to a set of tumor growth data.


  • Open Access

    Clinical and multiple gene expression variables in survival analysis of breast cancer: Analysis with the hypertabastic survival model

    by Mohammad A Tabatabai, Wayne M Eby, Nadim Nimeh, Hong Li, Karan P Singh

    Background: We explore the benefits of applying a new proportional hazard model to analyze survival of breast cancer patients. As a parametric model, the hypertabastic survival model offers a closer fit to experimental data than Cox regression, and furthermore provides explicit survival and hazard functions which can be used as additional tools in the survival analysis. In addition, one of our main concerns is utilization of multiple gene expression variables. Our analysis treats the important issue of interaction of different gene signatures in the survival analysis. Methods: The hypertabastic proportional hazards model was applied in survival analysis of breast cancer patients. This model was compared, using statistical measures of goodness of fit, with models based on the semi-parametric Cox proportional hazards model and the parametric log-logistic and Weibull models. The explicit functions for hazard and survival were then used to analyze the dynamic behavior of hazard and survival functions. Results: The hypertabastic model provided the best fit among all the models considered. Use of multiple gene expression variables also provided a considerable improvement in the goodness of fit of the model, as compared to use of only one. By utilizing the explicit survival and hazard functions provided by the model, we were able to determine the magnitude of the maximum rate of increase in hazard, and the maximum rate of decrease in survival, as well as the times when these occurred. We explore the influence of each gene expression variable on these extrema. Furthermore, in the cases of continuous gene expression variables, represented by a measure of correlation, we were able to investigate the dynamics with respect to changes in gene expression. Conclusions: We observed that use of three different gene signatures in the model provided a greater combined effect and allowed us to assess the relative importance of each in determination of outcome in this data set. These results point to the potential to combine gene signatures to a greater effect in cases where each gene signature represents some distinct aspect of the cancer biology. Furthermore we conclude that the hypertabastic survival models can be an effective survival analysis tool for breast cancer patients.


  • Reliability of Bridge Decks in Wisconsin

    by Habib Tabatabai, Mohammad Tabatabai, Chin-Wei Lee

    An accurate reliability model for bridge decks is important for effective long-term bridge deck management. The main objectives of this paper are to identify the most suitable reliability model for bridge decks in Wisconsin, and to utilize that model for detailed analyzes of bridge deck reliability and failure rates. The 2005 National Bridge Inventory (NBI) data for the State of Wisconsin were used. In this paper, the hypertabastic, Weibull, log logistic, and lognormal distributions are investigated. The end of service life is defined as the age of deck when rehabilitation or replacement is required (herein defined as a deck rating of between 4 and 5). The effects on NBI deck rating of average daily traffic (ADT), type of bridge superstructure (steel or concrete), and the deck surface area were considered. Based on the Akaike information criteria, the hypertabastic accelerated failure time model was selected as the most appropriate model for this study. Results show that deck area, type of superstructure ...


  • Mathematical modeling of stem cell proliferation

    by Mohammad A. Tabatabai, Zoran Bursac, Wayne M. Eby, Karan P. Singh

    The mathematical models prevalently used to represent stem cell proliferation do not have the level of accuracy that might be desired. The hyperbolastic growth models promise a greater degree of precision in representing data of stem cell proliferation. The hyperbolastic growth model H3 is applied to experimental data in both embryonic stem cells and adult mesenchymal stem cells. In the embryonic stem cells the results are compared with other popular models, including the Deasy model, which is used prevalently for stem cell growth. In the case of modelling adult mesenchymal stem cells, H3 is also successfully applied to describe the proliferative index. We demonstrated that H3 can accurately represent the dynamics of stem cell proliferation for both embryonic and adult mesenchymal stem cells. We also recognize the importance of additional factors, such as cytokines, in determining the rate of growth. We propose the question of how to extend H3 to a multivariable model that can include the influence of growth factors.


  • Open Access

    Hyperbolastic modeling of tumor growth with a combined treatment of iodoacetate and dimethylsulphoxide

    by Wayne M Eby, Mohammad A Tabatabai, Zoran Bursac

    An understanding of growth dynamics of tumors is important in understanding progression of cancer and designing appropriate treatment strategies. We perform a comparative study of the hyperbolastic growth models with the Weibull and Gompertz models, which are prevalently used in the field of tumor growth.


  • Open Access

    Hypertabastic survival model

    by Mohammad A Tabatabai, Zoran Bursac, David K Williams, Karan P Singh

    A new two-parameter probability distribution called hypertabastic is introduced to model the survival or time-to-event data. A simulation study was carried out to evaluate the performance of the hypertabastic distribution in comparison with popular distributions. We then demonstrate the application of the hypertabastic survival model by applying it to data from two motivating studies. The first one demonstrates the proportional hazards version of the model by applying it to a data set from multiple myeloma study. The second one demonstrates an accelerated failure time version of the model by applying it to data from a randomized study of glioma patients who underwent radiotherapy treatment with and without radiosensitizer misonidazole. Based on the results from the simulation study and two applications, the proposed model shows to be a flexible and promising alternative to practitioners in this field.